US Patent Issued to The University of Chicago on May 27 for "Treatment of demyelinating disorders" (Illinois Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,310,933, issued on May 27, was assigned to The University of Chicago (Chicago).

"Treatment of demyelinating disorders" was invented by Sharon Way (Chicago), Benjamin Clayton (Chicago) and Brian Popko (Chicago).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention discloses methods and compositions for the treatment of demyelinating disorders. Specifically, the invention relates to the use guanabenz or guanabenz derivative for treating demyelinating disorders."

The patent was filed on Jan. 25, 2021, under Application No. 17/248,432.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Pa...